Publications by authors named "David Hassman"

Claim this Profile
1
18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies.
Daniel Rutrick, Susan M Learned, Brent Boyett, David Hassman, Sunita Shinde

J Subst Use Addict Treat· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.
Anne C Andorn, Barbara R Haight, Sunita Shinde, Paul J Fudala, Yue Zhao, David Hassman

J Clin Psychopharmacol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab.
John D Davis, Ashish Bansal, David Hassman, Bolanle Akinlade, Meng Li

Clin Pharmacol Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and pharmacodynamics of the oral toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C.
Eric Lawitz, Daniel Gruener, Thomas Marbury, John Hill, Lynn Webster, David Hassman

Antivir Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful dose finding with sublingual fentanyl tablet: combined results from 2 open-label titration studies.
Srinivas R Nalamachu, Richard L Rauck, Mark S Wallace, David Hassman, Julian Howell

Pain Pract· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposure.
Rudy Onia, Ingrid Eshun-Wilson, Christina Arce, Christopher Ellis, Valentin Parvu, David Hassman

Curr Med Res Opin· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain.
Srinivas Nalamachu, David Hassman, Mark S Wallace, Sam Dumble, Rob Derrick

Curr Med Res Opin· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain.
Richard L Rauck, Marvin Tark, Eva Reyes, Teresa G Hayes, Anthony J Bartkowiak, David Hassman

Curr Med Res Opin· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.
William Insull, Jalal K Ghali, David R Hassman, Joseph W Y As, Sanjay K Gandhi

Mayo Clin Proc· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus.
Sherwyn Schwartz, David Hassman, John Shelmet, Richard Sievers, Richard Weinstein

Clin Ther· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient perception and use of an insulin injector/glucose monitor combined device.
Bruce Bode, John Shelmet, Brent Gooch, David R Hassman, John Liang

Diabetes Educ· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repaglinide versus nateglinide monotherapy: a randomized, multicenter study.
Julio Rosenstock, David R Hassman, Robert D Madder, Shari A Brazinsky, James Farrell

Diabetes Care· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone.
Lois Jovanovic, David R Hassman, Brent Gooch, Rajeev Jain, Susan Greco

Diabetes Res Clin Pract· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
Lorenzo Melani, Richard Mills, David Hassman, Robert Lipetz, Leslie Lipka

Eur Heart J· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
W Virgil Brown, Harold E Bays, David R Hassman, James McKenney, Rohini Chitra

Am Heart J· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis